These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37247233)

  • 1. In Silico Evaluation of SARS-CoV-2 K417N, L452R, and E484K Detection Assays Against Omicron Variants.
    Sayan M; Arikan A; Isbilen M
    New Microbiol; 2023 May; 46(2):133-140. PubMed ID: 37247233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
    Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
    J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution.
    Liotti FM; De Maio F; Ippoliti C; Santarelli G; Monzo FR; Sali M; Santangelo R; Ceccherini-Silberstein F; Sanguinetti M; Posteraro B
    Microbiol Spectr; 2022 Dec; 10(6):e0292222. PubMed ID: 36409091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact.
    Vega-Magaña N; Sánchez-Sánchez R; Hernández-Bello J; Venancio-Landeros AA; Peña-Rodríguez M; Vega-Zepeda RA; Galindo-Ornelas B; Díaz-Sánchez M; García-Chagollán M; Macedo-Ojeda G; García-González OP; Muñoz-Valle JF
    Front Cell Infect Microbiol; 2021; 11():672562. PubMed ID: 34123874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal genome diversity of SARS-CoV-2 in wastewater: a two-year global epidemiological study.
    Mandal M; Mandal S
    Environ Monit Assess; 2023 Dec; 196(1):44. PubMed ID: 38102322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A RT-qPCR system using a degenerate probe for specific identification and differentiation of SARS-CoV-2 Omicron (B.1.1.529) variants of concern.
    Jessen R; Nielsen L; Larsen NB; Cohen AS; Gunalan V; Marving E; Alfaro-Núñez A; Polacek C; ; Fomsgaard A; Spiess K
    PLoS One; 2022; 17(10):e0274889. PubMed ID: 36197885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
    Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
    Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.
    Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF
    Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021.
    Subramoney K; Mtileni N; Bharuthram A; Davis A; Kalenga B; Rikhotso M; Maphahlele M; Giandhari J; Naidoo Y; Pillay S; Ramphal U; Ramphal Y; Tegally H; Wilkinson E; Mohale T; Ismail A; Mashishi B; Mbenenge N; de Oliveira T; Makatini Z; Fielding BC; Treurnicht FK;
    J Med Virol; 2022 Aug; 94(8):3676-3684. PubMed ID: 35441368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
    Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
    J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
    Tsai MS; Shih WT; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2022 May; 149():112802. PubMed ID: 35279013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics.
    Oh C; Sashittal P; Zhou A; Wang L; El-Kebir M; Nguyen TH
    Appl Environ Microbiol; 2022 Apr; 88(7):e0228921. PubMed ID: 35285246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-step process for in silico screening to assess the performance of qRTPCR kits against variant strains of SARS-CoV-2.
    Gupta S; Kumar A; Gupta N; Bharti DR; Aggarwal N; Ravi V
    BMC Genomics; 2022 Nov; 23(1):755. PubMed ID: 36384483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Lateral Flow-Based Assay for Simple and Visual Detection of SARS-CoV-2 Mutations.
    Gomez-Martinez J; Henry S; Tuaillon E; Van de Perre P; Fournier-Wirth C; Foulongne V; Brès JC
    Front Cell Infect Microbiol; 2022; 12():902914. PubMed ID: 35909973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs.
    Chakraborty C; Bhattacharya M; Sharma AR; Dhama K; Agoramoorthy G
    Geroscience; 2022 Oct; 44(5):2393-2425. PubMed ID: 35989365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
    Borillo GA; Kagan RM; Marlowe EM
    Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
    Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.